Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04784975 · ClinicalTrials.gov registry record
Bone Health and Microbiome in Persons With Type 1 Diabetes
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 26
- Enrollment target
NCT04784975: Completed study, sponsored by Indiana University.
NCT04784975 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04784975 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
It is well-established that persons with type 1 diabetes (T1D) are at an increased risk for morbidity and mortality related to bone fracture due to poor bone health, however we do not fully understand the mechanism behind the increased fracture risk. We are examining bone health and the microbiome in adolescents and young adults with type 1 diabetes to better understand the reasons behind this increased risk.
Primary Outcome
Our primary outcome is HRpQCT strength of cortical and trabecular bone.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2021-04-23 |
| Est. Completion | 2022-09-23 |
What the finished NCT04784975 record still lists
NCT04784975 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT04784975 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04784975 about?
NCT04784975 is a clinical study titled "Bone Health and Microbiome in Persons With Type 1 Diabetes". It is well-established that persons with type 1 diabetes (T1D) are at an increased risk for morbidity and mortality related to bone fracture due to poor bone health, however we do not fully understand the mechanism behind the increased fracture risk. We are examining bone health and the microbiome i...
What is the current status of trial NCT04784975?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2021-04-23. Estimated completion is 2022-09-23.
What interventions are being tested in trial NCT04784975?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT04784975?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI